Financial Fitness Check: Examining Zomedica Corp (ZOM)’s Key Ratios

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

In the latest session, Zomedica Corp (AMEX: ZOM) closed at $0.14 up 2.65% from its previous closing price of $0.14. In other words, the price has increased by $2.65 from its previous closing price. On the day, 4.85 million shares were traded. ZOM stock price reached its highest trading level at $0.1435 during the session, while it also had its lowest trading level at $0.1372.


For a deeper understanding of Zomedica Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.87 and its Current Ratio is at 11.50. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Dawson James on January 06, 2023, initiated with a Buy rating and assigned the stock a target price of $6.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 13 ’24 when HEATON LARRY C II bought 100,000 shares for $0.14 per share. The transaction valued at 14,200 led to the insider holds 300,000 shares of the business.

POWERS JOHNNY D bought 100,000 shares of ZOM for $16,500 on Dec 15 ’23. The Director now owns 1,950 shares after completing the transaction at $0.17 per share. On Nov 17 ’23, another insider, POWERS JOHNNY D, who serves as the Director of the company, bought 100,000 shares for $0.17 each. As a result, the insider paid 16,600 and bolstered with 1,850,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZOM now has a Market Capitalization of 136899008 and an Enterprise Value of 56440968. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.27 while its Price-to-Book (P/B) ratio in mrq is 0.59. Its current Enterprise Value per Revenue stands at 2.174 whereas that against EBITDA is -2.045.

Stock Price History:

The Beta on a monthly basis for ZOM is 0.84, which has changed by -0.3034826 over the last 52 weeks, in comparison to a change of 0.2704494 over the same period for the S&P500. Over the past 52 weeks, ZOM has reached a high of $0.25, while it has fallen to a 52-week low of $0.12. The 50-Day Moving Average of the stock is 0.43%, while the 200-Day Moving Average is calculated to be -13.87%.

Shares Statistics:

For the past three months, ZOM has traded an average of 5.24M shares per day and 7250400 over the past ten days. A total of 979.95M shares are outstanding, with a floating share count of 964.36M. Insiders hold about 1.59% of the company’s shares, while institutions hold 8.48% stake in the company. Shares short for ZOM as of 1714435200 were 60248826 with a Short Ratio of 11.49, compared to 1711584000 on 63985925. Therefore, it implies a Short% of Shares Outstanding of 60248826 and a Short% of Float of 6.260000000000001.

Most Popular

[the_ad id="945"]